预防 COPD 患者再入院：需要更多前瞻性研究。
Preventing readmissions of COPD patients: more prospective studies are needed.
机构信息
Pneumology Dept, Hospital Universitari Vall d'Hebron/Vall d'Hebron Research Institute, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
出版信息
Eur Respir Rev. 2020 Jun 3;29(156). doi: 10.1183/16000617.0097-2020. Print 2020 Jun 30.
Abstract
摘要
[文献链接]
相似文献
1
Preventing readmissions of COPD patients: more prospective studies are needed.预防 COPD 患者再入院：需要更多前瞻性研究。
Eur Respir Rev. 2020 Jun 3;29(156). doi: 10.1183/16000617.0097-2020. Print 2020 Jun 30.
2
Hospital readmissions for COPD: a retrospective longitudinal study.慢性阻塞性肺疾病（COPD）患者的医院再入院情况：一项回顾性纵向研究。
NPJ Prim Care Respir Med. 2017 Apr 27;27(1):31. doi: 10.1038/s41533-017-0028-8.
3
Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.2009 年至 2014 年佛罗里达州慢性阻塞性肺疾病（COPD）患者再入院率、住院费用和死亡率趋势。
Clin Ther. 2018 Apr;40(4):613-626.e1. doi: 10.1016/j.clinthera.2018.03.006. Epub 2018 Mar 31.
4
The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006-2015.医院再入院率降低计划与慢性阻塞性肺疾病的再入院情况，2006 - 2015年
Ann Am Thorac Soc. 2020 Apr;17(4):450-456. doi: 10.1513/AnnalsATS.201909-672OC.
5
Results of a Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions.医疗保险改善慢性阻塞性肺疾病再入院护理捆绑支付计划的结果。
Ann Am Thorac Soc. 2017 May;14(5):643-648. doi: 10.1513/AnnalsATS.201610-775BC.
6
Reliable adherence to a COPD care bundle mitigates system-level failures and reduces COPD readmissions: a system redesign using improvement science.可靠地遵循 COPD 护理包可减轻系统层面的失败并降低 COPD 再入院率：使用改进科学进行系统重新设计。
BMJ Qual Saf. 2017 Nov;26(11):908-918. doi: 10.1136/bmjqs-2017-006529. Epub 2017 Jul 21.
7
Reducing COPD readmissions: great promise but big problems.降低慢性阻塞性肺疾病（COPD）再入院率：前景广阔但问题重重。
Chest. 2015 May;147(5):1199-201. doi: 10.1378/chest.15-0380.
8
Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.抑郁症与慢性阻塞性肺疾病急性加重再入院有关。
Ann Am Thorac Soc. 2016 Feb;13(2):197-203. doi: 10.1513/AnnalsATS.201507-439OC.
9
Chronic Obstructive Pulmonary Disease Readmissions and Other Measures of Hospital Quality.慢性阻塞性肺疾病再入院情况及医院质量的其他衡量指标
Am J Respir Crit Care Med. 2017 Jul 1;196(1):47-55. doi: 10.1164/rccm.201609-1944OC.
10
Hospital readmissions for COPD in England are rising, audit shows.审计显示，英格兰慢性阻塞性肺疾病（COPD）患者的医院再入院率正在上升。
BMJ. 2017 Jan 31;356:j557. doi: 10.1136/bmj.j557.
引用本文的文献
1
Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies.降低慢性阻塞性肺疾病患者的再入院率：当前治疗方法和预防策略
Medicina (Kaunas). 2025 Jan 9;61(1):97. doi: 10.3390/medicina61010097.
2
Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study.30 天和 90 天 COPD 加重再入院的预测因素：一项前瞻性队列研究。
Int J Chron Obstruct Pulmon Dis. 2021 Oct 7;16:2769-2781. doi: 10.2147/COPD.S328030. eCollection 2021.
3
High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.高血嗜酸性粒细胞和 YKL-40 水平以及低 CXCL9 水平与慢性阻塞性肺疾病急性加重患者的再入院率增加相关。
Int J Chron Obstruct Pulmon Dis. 2021 Mar 26;16:795-806. doi: 10.2147/COPD.S294968. eCollection 2021.
本文引用的文献
1
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis.慢性阻塞性肺疾病恶化后全因住院再入院的危险因素：系统评价和荟萃分析。
Eur Respir Rev. 2020 Jun 3;29(156). doi: 10.1183/16000617.0166-2019. Print 2020 Jun 30.
2
Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.常规血液生物标志物与慢性阻塞性肺疾病的临床表型和加重的关系。
Int J Chron Obstruct Pulmon Dis. 2020 Mar 31;15:681-690. doi: 10.2147/COPD.S240720. eCollection 2020.
3
Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study.基于人群的研究：血嗜酸性粒细胞计数及其变异性与 COPD 加重的风险。
Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):13-20. doi: 10.1016/j.arbres.2019.12.015. Epub 2020 Feb 13.
4
Acute Phase Proteins as Predictors of Survival in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation.急性加重期慢性阻塞性肺疾病机械通气患者急性相蛋白作为生存预测因子。
COPD. 2020 Feb;17(1):22-28. doi: 10.1080/15412555.2019.1698019. Epub 2019 Dec 10.
5
Social Profile of Patients Admitted for COPD Exacerbations. A Gender Analysis.慢性阻塞性肺病加重患者的社会特征。性别分析。
Arch Bronconeumol (Engl Ed). 2020 Feb;56(2):84-89. doi: 10.1016/j.arbres.2019.03.009. Epub 2019 Apr 11.
6
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.全球慢性阻塞性肺疾病诊断、管理和预防策略：GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
7
Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes.西班牙呼吸内科诊治的慢性阻塞性肺疾病（COPD）患者的特征，根据慢性阻塞性肺疾病全球倡议（GOLD）分组和GesEPOC临床表型
Arch Bronconeumol (Engl Ed). 2018 Nov;54(11):559-567. doi: 10.1016/j.arbres.2018.03.021. Epub 2018 May 28.
8
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.血浆纤维蛋白原鉴定作为慢性阻塞性肺疾病药物研发工具。慢性阻塞性肺疾病生物标志物鉴定联盟的观点。
Am J Respir Crit Care Med. 2016 Mar 15;193(6):607-13. doi: 10.1164/rccm.201509-1722PP.
9
Factors associated with inpatient readmission among managed care enrollees with COPD.慢性阻塞性肺疾病管理式医疗参保者住院再入院相关因素
Hosp Pract (1995). 2015;43(4):199-207. doi: 10.1080/21548331.2015.1085797. Epub 2015 Sep 10.
10
Factors associated with depression and severe depression in patients with COPD.慢性阻塞性肺疾病（COPD）患者中与抑郁和重度抑郁相关的因素。
Respir Med. 2014 Nov;108(11):1615-25. doi: 10.1016/j.rmed.2014.08.010. Epub 2014 Sep 6.
Zotero 插件